FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997561837> ?p ?o ?g. }

• W2997561837 endingPage "446" @default.
• W2997561837 startingPage "435" @default.
• W2997561837 abstract "Despite increasing recognition of the importance of immune checkpoint inhibitor-associated AKI, data on this complication of immunotherapy are sparse.We conducted a multicenter study of 138 patients with immune checkpoint inhibitor-associated AKI, defined as a ≥2-fold increase in serum creatinine or new dialysis requirement directly attributed to an immune checkpoint inhibitor. We also collected data on 276 control patients who received these drugs but did not develop AKI.Lower baseline eGFR, proton pump inhibitor use, and combination immune checkpoint inhibitor therapy were each independently associated with an increased risk of immune checkpoint inhibitor-associated AKI. Median (interquartile range) time from immune checkpoint inhibitor initiation to AKI was 14 (6-37) weeks. Most patients had subnephrotic proteinuria, and approximately half had pyuria. Extrarenal immune-related adverse events occurred in 43% of patients; 69% were concurrently receiving a potential tubulointerstitial nephritis-causing medication. Tubulointerstitial nephritis was the dominant lesion in 93% of the 60 patients biopsied. Most patients (86%) were treated with steroids. Complete, partial, or no kidney recovery occurred in 40%, 45%, and 15% of patients, respectively. Concomitant extrarenal immune-related adverse events were associated with worse renal prognosis, whereas concomitant tubulointerstitial nephritis-causing medications and treatment with steroids were each associated with improved renal prognosis. Failure to achieve kidney recovery after immune checkpoint inhibitor-associated AKI was independently associated with higher mortality. Immune checkpoint inhibitor rechallenge occurred in 22% of patients, of whom 23% developed recurrent associated AKI.This multicenter study identifies insights into the risk factors, clinical features, histopathologic findings, and renal and overall outcomes in patients with immune checkpoint inhibitor-associated AKI." @default.
• W2997561837 created "2020-01-10" @default.
• W2997561837 creator A5000484881 @default.
• W2997561837 creator A5002639615 @default.
• W2997561837 creator A5002989368 @default.
• W2997561837 creator A5003600825 @default.
• W2997561837 creator A5011834461 @default.
• W2997561837 creator A5015941931 @default.
• W2997561837 creator A5020460043 @default.
• W2997561837 creator A5024920902 @default.
• W2997561837 creator A5025067315 @default.
• W2997561837 creator A5032181570 @default.
• W2997561837 creator A5035343389 @default.
• W2997561837 creator A5038210938 @default.
• W2997561837 creator A5040646631 @default.
• W2997561837 creator A5041174414 @default.
• W2997561837 creator A5045080405 @default.
• W2997561837 creator A5046425715 @default.
• W2997561837 creator A5048669465 @default.
• W2997561837 creator A5049876122 @default.
• W2997561837 creator A5052100524 @default.
• W2997561837 creator A5054920589 @default.
• W2997561837 creator A5056186554 @default.
• W2997561837 creator A5057631025 @default.
• W2997561837 creator A5057918973 @default.
• W2997561837 creator A5059248910 @default.
• W2997561837 creator A5067826298 @default.
• W2997561837 creator A5071446768 @default.
• W2997561837 creator A5071570508 @default.
• W2997561837 creator A5076920874 @default.
• W2997561837 creator A5083488593 @default.
• W2997561837 creator A5083855458 @default.
• W2997561837 creator A5090696844 @default.
• W2997561837 date "2020-01-02" @default.
• W2997561837 modified "2023-10-13" @default.
• W2997561837 title "Clinical Features and Outcomes of Immune Checkpoint Inhibitor–Associated AKI: A Multicenter Study" @default.
• W2997561837 cites W1860317768 @default.
• W2997561837 cites W1965491136 @default.
• W2997561837 cites W2021988356 @default.
• W2997561837 cites W2030207051 @default.
• W2997561837 cites W2061608024 @default.
• W2997561837 cites W2096760252 @default.
• W2997561837 cites W2105057287 @default.
• W2997561837 cites W2109578737 @default.
• W2997561837 cites W2128802116 @default.
• W2997561837 cites W2138461176 @default.
• W2997561837 cites W2141701308 @default.
• W2997561837 cites W2166662937 @default.
• W2997561837 cites W2338242614 @default.
• W2997561837 cites W2413514895 @default.
• W2997561837 cites W2572174216 @default.
• W2997561837 cites W2736166064 @default.
• W2997561837 cites W2746991247 @default.
• W2997561837 cites W2753432434 @default.
• W2997561837 cites W2783137027 @default.
• W2997561837 cites W2786816161 @default.
• W2997561837 cites W2794675594 @default.
• W2997561837 cites W2796582438 @default.
• W2997561837 cites W2809773917 @default.
• W2997561837 cites W2887577080 @default.
• W2997561837 cites W2900322133 @default.
• W2997561837 cites W2905500595 @default.
• W2997561837 cites W2914287567 @default.
• W2997561837 cites W2914696936 @default.
• W2997561837 cites W2943781197 @default.
• W2997561837 cites W2943820705 @default.
• W2997561837 doi "https://doi.org/10.1681/asn.2019070676" @default.
• W2997561837 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7003302" @default.
• W2997561837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31896554" @default.
• W2997561837 hasPublicationYear "2020" @default.
• W2997561837 type Work @default.
• W2997561837 sameAs 2997561837 @default.
• W2997561837 citedByCount "222" @default.
• W2997561837 countsByYear W29975618372020 @default.
• W2997561837 countsByYear W29975618372021 @default.
• W2997561837 countsByYear W29975618372022 @default.
• W2997561837 countsByYear W29975618372023 @default.
• W2997561837 crossrefType "journal-article" @default.
• W2997561837 hasAuthorship W2997561837A5000484881 @default.
• W2997561837 hasAuthorship W2997561837A5002639615 @default.
• W2997561837 hasAuthorship W2997561837A5002989368 @default.
• W2997561837 hasAuthorship W2997561837A5003600825 @default.
• W2997561837 hasAuthorship W2997561837A5011834461 @default.
• W2997561837 hasAuthorship W2997561837A5015941931 @default.
• W2997561837 hasAuthorship W2997561837A5020460043 @default.
• W2997561837 hasAuthorship W2997561837A5024920902 @default.
• W2997561837 hasAuthorship W2997561837A5025067315 @default.
• W2997561837 hasAuthorship W2997561837A5032181570 @default.
• W2997561837 hasAuthorship W2997561837A5035343389 @default.
• W2997561837 hasAuthorship W2997561837A5038210938 @default.
• W2997561837 hasAuthorship W2997561837A5040646631 @default.
• W2997561837 hasAuthorship W2997561837A5041174414 @default.
• W2997561837 hasAuthorship W2997561837A5045080405 @default.
• W2997561837 hasAuthorship W2997561837A5046425715 @default.
• W2997561837 hasAuthorship W2997561837A5048669465 @default.
• W2997561837 hasAuthorship W2997561837A5049876122 @default.
• W2997561837 hasAuthorship W2997561837A5052100524 @default.
• W2997561837 hasAuthorship W2997561837A5054920589 @default.

• next